283 related articles for article (PubMed ID: 25894167)
1. Evaluation of late antibody-mediated rejection (C4d-mediated rejection): a single-center experience.
Tatar E; Uslu A; Simsek C; Vardar E
Exp Clin Transplant; 2015 Apr; 13 Suppl 1():259-62. PubMed ID: 25894167
[TBL] [Abstract][Full Text] [Related]
2. Concurrent acute cellular rejection is an independent risk factor for renal allograft failure in patients with C4d-positive antibody-mediated rejection.
Matignon M; Muthukumar T; Seshan SV; Suthanthiran M; Hartono C
Transplantation; 2012 Sep; 94(6):603-11. PubMed ID: 22932115
[TBL] [Abstract][Full Text] [Related]
3. Antibody-mediated rejection and treatment in pediatric patients: one center's experience.
Gulleroglu K; Baskin E; Bayrakci US; Turan M; Ozdemir BH; Moray G; Karakayali H; Haberal M
Exp Clin Transplant; 2013 Oct; 11(5):404-7. PubMed ID: 24128133
[TBL] [Abstract][Full Text] [Related]
4. C4d-negative antibody-mediated rejection: A pathologist's perspective and clinical outcome.
Nigam LK; Vanikar AV; Kanodia KV; Patel RD; Suthar KS; Patel HV
Saudi J Kidney Dis Transpl; 2018; 29(1):39-49. PubMed ID: 29456206
[TBL] [Abstract][Full Text] [Related]
5. The impact of C4d staining as a humoral injury marker.
Kara M; Demir F; Ata P; Ozel L; Gumrukcu G; Unal E; Canbakan M; Gucun M; Esadoglu V; Ozdemir E; Cemel H; Titiz MI
Transplant Proc; 2012; 44(6):1694-6. PubMed ID: 22841245
[TBL] [Abstract][Full Text] [Related]
6. Expression patterns of B cells in acute kidney transplant rejection.
Carpio VN; Noronha Ide L; Martins HL; Jobim LF; Gil BC; Külzer AS; Loreto Mda S; Gonçalves LF; Manfro RC; Veronese FV
Exp Clin Transplant; 2014 Oct; 12(5):405-14. PubMed ID: 25299368
[TBL] [Abstract][Full Text] [Related]
7. Differences in pathologic features and graft outcomes in antibody-mediated rejection of renal allografts due to persistent/recurrent versus de novo donor-specific antibodies.
Haas M; Mirocha J; Reinsmoen NL; Vo AA; Choi J; Kahwaji JM; Peng A; Villicana R; Jordan SC
Kidney Int; 2017 Mar; 91(3):729-737. PubMed ID: 28104301
[TBL] [Abstract][Full Text] [Related]
8. Capillary C4d and Kidney Allograft Outcome in Relation to Morphologic Lesions Suggestive of Antibody-Mediated Rejection.
Kikić Ž; Kainz A; Kozakowski N; Oberbauer R; Regele H; Bond G; Böhmig GA
Clin J Am Soc Nephrol; 2015 Aug; 10(8):1435-43. PubMed ID: 26071493
[TBL] [Abstract][Full Text] [Related]
9. A Banff Component Scoring-based Histologic Assessment of Bortezomib-based Antibody-mediated Rejection Therapy.
Sadaka B; Ejaz NS; Shields AR; Cardi MA; Wadih G; Witte D; Abu Jawdeh BG; Alloway RR; Woodle ES
Transplantation; 2015 Aug; 99(8):1691-9. PubMed ID: 25803498
[TBL] [Abstract][Full Text] [Related]
10. C4d deposits in acute "cell-mediated" rejection: a marker for renal prognosis?
Neves M; Cotovio P; Machado S; Santos L; Macário F; Alves R; Pratas J; Xavier da Cunha M; Mota A; Campos M
Transplant Proc; 2012 Oct; 44(8):2360-5. PubMed ID: 23026593
[TBL] [Abstract][Full Text] [Related]
11. The effect of histopathologic and clinical features on allograft survival in renal transplant patients with antibody-mediated rejection.
Akagun T; Yazici H; Caliskan Y; Ozluk Y; Sahin S; Turkmen A; Kılıcaslan I; Sever MS
Ren Fail; 2017 Nov; 39(1):19-25. PubMed ID: 27776435
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic analysis of acute vascular rejection cases after renal transplantation.
Shimizu T; Tanabe T; Omoto K; Ishida H; Tanabe K
Transplant Proc; 2012 Jan; 44(1):230-5. PubMed ID: 22310621
[TBL] [Abstract][Full Text] [Related]
13. Clinical and pathological analyses of transplant glomerulopathy cases.
Shimizu T; Ishida H; Toki D; Nozaki T; Omoto K; Tanabe K; Honda K; Koike J
Nephrology (Carlton); 2014 Jun; 19 Suppl 3():21-6. PubMed ID: 24842817
[TBL] [Abstract][Full Text] [Related]
14. Detection of Complement-binding Donor-specific Antibodies, Not IgG-antibody Strength Nor C4d Status, at Antibody-mediated Rejection Diagnosis Is an Independent Predictor of Kidney Graft Failure.
Malheiro J; Santos S; Tafulo S; Dias L; Martins S; Fonseca I; Almeida M; Pedroso S; Beirão I; Castro-Henriques A; Cabrita A
Transplantation; 2018 Nov; 102(11):1943-1954. PubMed ID: 29757900
[TBL] [Abstract][Full Text] [Related]
15. Rejection of the Renal Allograft in the Absence of Demonstrable Antibody and Complement.
Zhao X; Huang G; Randhawa S; Zeng G; Lunz J; Randhawa P
Transplantation; 2017 Feb; 101(2):395-401. PubMed ID: 26901079
[TBL] [Abstract][Full Text] [Related]
16. Acute Antibody-Mediated Rejection in Kidney Transplant Based on the 2013 Banff Criteria: Single-Center Experience in Uruguay.
Nin M; Coitiño R; Kurdian M; Orihuela L; Astesiano R; Garau M; López D; Rievas G; Rodriguez I; González-Martínez F; Noboa O
Transplant Proc; 2016 Mar; 48(2):612-5. PubMed ID: 27110014
[TBL] [Abstract][Full Text] [Related]
17. Persistent C4d and antibody-mediated rejection in pediatric renal transplant patients.
South AM; Maestretti L; Kambham N; Grimm PC; Chaudhuri A
Pediatr Transplant; 2017 Nov; 21(7):. PubMed ID: 28833936
[TBL] [Abstract][Full Text] [Related]
18. C4D deposition and positive posttransplant crossmatch are not necessarily markers of antibody-mediated rejection in renal allograft recipients.
Banasik M; Boratyńska M; Nowakowska B; Haloń A; Kościelska-Kasprzak K; Drulis-Fajdasz D; Patrzałek D; Weyde W; Klinger M
Transplant Proc; 2007 Nov; 39(9):2718-20. PubMed ID: 18021967
[TBL] [Abstract][Full Text] [Related]
19. Peritubular capillary C4d staining in late acute renal allograft rejection--is it relevant?
Satoskar AA; Lehman AM; Nadasdy GM; Sedmak DD; Pesavento TE; Henry ML; Pelletier RP; Ferguson RM; Nadasdy T
Clin Transplant; 2008; 22(1):61-7. PubMed ID: 18217907
[TBL] [Abstract][Full Text] [Related]
20. The Relationship of the Severity and Category of Acute Rejection With Intimal Arteritis Defined in Banff Classification to Clinical Outcomes.
Wu K; Budde K; Schmidt D; Neumayer HH; Rudolph B
Transplantation; 2015 Aug; 99(8):e105-14. PubMed ID: 25719260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
